F-group (family)
108.1.1.1 EF-hand_1
Ligands and drugs
296
Member domains
71
with ligand contacts (≤ 4 Å)
24.0% of members
22
with DrugDomain annotations
7.4% of members
8
with a DrugBank compound
2.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 108.1.1.1 belongs to X-group 108 EF-hand, which binds 8.0 ligand superclasses per 20 proteins, broader than 56% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04757 | P2G | GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE | 3 |
| DB00160 | ALA | Alanine | 1 |
| DB02343 | P3G | 3,6,9,12,15-Pentaoxaheptadecane | 1 |
| DB11093 | — | — | 1 |
| DB11348 | — | — | 1 |
| DB13800 | — | — | 1 |
| DB14481 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 61 |
| NAmetal | SODIUM ION | 15 |
| HEB | HEME B/C | 8 |
| 117 | 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID | 4 |
| SIN | SUCCINIC ACID | 4 |
| P6G | HEXAETHYLENE GLYCOL | 2 |
| A1IPH | (5-methyl-2-oxidanylidene-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxidanylidene-4~{H}-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate | 1 |
| FKW | 2-(1~{H}-indol-3-yl)-~{N}-[(~{E})-(4-nitro-3-oxidanyl-phenyl)methylideneamino]ethanamide | 1 |
| P2G | (2S,4R,6R,6AS)-4-(2-AMINO-6-OXO-1,6-DIHYDROPURIN-9-YL)-6-(HYDROXYMETHYL)-TETRAHYDROFURO[3,4-D][1,3]DIOXOL-2-YLPHOSPHONIC ACID | 1 |
| P3G | 3,6,9,12,15-PENTAOXAHEPTADECANE | 1 |
| UNX | UNKNOWN ATOM OR ION | 1 |
| YG7 | 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide | 1 |